Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca delays PD-L1 data in rejig of phase 3 program
AstraZeneca delays PD-L1 data in rejig of phase 3 program
AstraZeneca delays PD-L1 data in rejig of phase 3 program
Submitted by
admin
on January 17, 2017 - 10:02am
Source:
Fierce Biotech
News Tags:
AstraZeneca
anti-PD-L1
clinical trials
tremelimumab
durvalumab
Headline:
AstraZeneca delays PD-L1 data in rejig of phase 3 program
Do Not Allow Advertisers to Use My Personal information
